---
figid: PMC11978139__12935_2025_3765_Fig2_HTML
figtitle: Molecular processes underlying CXCL2 secretion
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11978139
filename: 12935_2025_3765_Fig2_HTML.jpg
figlink: /pmc/articles/PMC11978139/figure/F2/
number: F2
caption: 'Molecular processes underlying CXCL2 secretion. The illustration depicts
  multiple interacting molecular pathways involved in the secretion of CXCL2. The
  processes encompass: LPS-induced CXCL2, IL-6, IL-1β, and TNF-α via the NF-κB/MAPK
  signaling pathway; IL-6 facilitating CXCL2 induction through the NF-κB/MAPK pathway;
  TNF-α promoting CXCL2 induction via both the NF-κB/MAPK and caspase-3 pathways;
  FasL inducing CXCL2 through the caspase-3 pathway; Ca2+ and ATP stimulating CXCL2
  induction through the PI3K signaling pathway; IL-1β facilitating CXCL2 induction
  via the NF-κB/MAPK pathway; and IFN-γ and IL-10 inhibiting CXCL2, IL-6, IL-1β, and
  TNF-α induction through the JAK/STAT3 signaling pathway, with SOCS3 mediating JAK/STAT3
  inhibition. TNF-α: tumor necrosis factor-alpha; IFN-γ: interferon-gamma; IL: interleukin;
  LPS: lipopolysaccharide'
papertitle: 'CXCL2: a key player in the tumor microenvironment and inflammatory diseases'
reftext: Yuanhao Lv, et al. Cancer Cell Int. 2025;25(NA).
year: '2025'
doi: 10.1186/s12935-025-03765-3
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BMC
keywords: Chemokine | CXCL2 | Tumor microenvironment | Inflammatory diseases | Targeted
  therapies
automl_pathway: 0.7572686
figid_alias: PMC11978139__F2
figtype: Figure
redirect_from: /figures/PMC11978139__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11978139__12935_2025_3765_Fig2_HTML.html
  '@type': Dataset
  description: 'Molecular processes underlying CXCL2 secretion. The illustration depicts
    multiple interacting molecular pathways involved in the secretion of CXCL2. The
    processes encompass: LPS-induced CXCL2, IL-6, IL-1β, and TNF-α via the NF-κB/MAPK
    signaling pathway; IL-6 facilitating CXCL2 induction through the NF-κB/MAPK pathway;
    TNF-α promoting CXCL2 induction via both the NF-κB/MAPK and caspase-3 pathways;
    FasL inducing CXCL2 through the caspase-3 pathway; Ca2+ and ATP stimulating CXCL2
    induction through the PI3K signaling pathway; IL-1β facilitating CXCL2 induction
    via the NF-κB/MAPK pathway; and IFN-γ and IL-10 inhibiting CXCL2, IL-6, IL-1β,
    and TNF-α induction through the JAK/STAT3 signaling pathway, with SOCS3 mediating
    JAK/STAT3 inhibition. TNF-α: tumor necrosis factor-alpha; IFN-γ: interferon-gamma;
    IL: interleukin; LPS: lipopolysaccharide'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - TNF
  - TLR4
  - TNFRSF1A
  - MAPK8
  - FASLG
  - FAS
  - FASN
  - NFKB1
  - STAT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOCS3
  - IL1A
  - IL1B
  - IL1R1
  - IL6
  - IL6R
  - IL10
  - IL10RA
  - MAPK3
  - MAPK1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CXCL2
  - P2RY2
  - ATP8A2
  - tnfb
  - mapk8b
  - faslg
  - fas
  - stat3
  - socs3a
  - il1rl1
  - il6
  - il6r
  - il10
  - mapk3
  - LPS
  - TNF-a
  - Fas
  - Ca2+
  - ATP
---
